Develops a prognostic model for predicting progression-free survival in DLBCL, highlighting potential for personalized care.
Objective: This study aimed to develop a multi-modal ultrasound-based model integrating radiomics, deep learning, and clinical features to predict progression-free survival (PFS) in diffuse large B-cell lymphoma (DLBCL) with superficial lymph node involvement. Methods: A total of 281 DLBCL patients with superficial lymph node involvement treated with standard regimens were retrospectively enrolled and assigned to training and test sets at a 7:3 ratio. Ultrasound radiomic features were extracted by PyRadiomics, and deep learning features were derived from DenseNet121 with transfer learning. After Pearson’s correlation filtering and least absolute shrinkage and selection operator (LASSO)-Cox regression for feature selection, five prognostic models were compared using C-index, time-dependent Area Under the Curve (AUC), risk stratification and decision curve analysis. Results: The combined model achieved the highest C-index of 0.811 in the test set, with 1-/2-/3-year PFS AUCs of 0.826, 0.812, and 0.810, respectively. Risk stratification showed significantly poorer PFS in the high-risk group (p < 0.01). A visualized nomogram was further developed as a preliminary reference for individualized prediction. Conclusions: This multi-modal combined predictive model and corresponding nomogram based on superficial lymph node features showed promising potential for practical and intuitive prognostic assessment and risk stratification in DLBCL.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: